MENU
Home
Add Document
Sign In
Create An Account
PDF Reader
Full Text
The New England Journal of Medicine Downloaded from nejm.org at UNIVERSITY OF OTAGO on November 15, 2015. For personal use only. No other uses without permission. From the NEJM Archive. Copyright © 2010 Massachusetts Medical Society. All rights reserved.
The New England Journal of Medicine Downloaded from nejm.org at UNIVERSITY OF OTAGO on November 15, 2015. For personal use only. No other uses without permission. From the NEJM Archive. Copyright © 2010 Massachusetts Medical Society. All rights reserved.
The New England Journal of Medicine Downloaded from nejm.org at UNIVERSITY OF OTAGO on November 15, 2015. For personal use only. No other uses without permission. From the NEJM Archive. Copyright © 2010 Massachusetts Medical Society. All rights reserved.
Suggest Documents
Effects of bromocriptine on pituitary tumour size.
Bromocriptine in pituitary tumours.
Bromocriptine and pituitary disorders.
Bromocriptine therapy in acromegaly.
Effect of delay in retroperfusion therapy on infarct size reduction.
Bromocriptine and Triac therapy for hyperthyroidism due to pituitary resistance to thyroid hormone.
Pituitary tumours during pregnancy in mothers treated with bromocriptine.
Pituitary size in depression.
Regression of pituitary prolactinoma after treatment with bromocriptine.
Hyperlipoproteinemia induced by a transplantable pituitary tumor in the rat.
Rapid deterioration of visual fields during bromocriptine-induced pregnancy in a patient with a pituitary adenoma.
Reduction by pituitary grafts of mammary tumor age. Its variability in a high mammary tumor strain of mice: effects on mammary DNA synthesis.
PITUITARY MRI FINDINGS IN PATIENTS WITH PITUITARY AND ECTOPIC ACTH-DEPENDENT CUSHING SYNDROME: DOES A 6-MM PITUITARY TUMOR SIZE CUT-OFF VALUE EXCLUDE ECTOPIC ACTH SYNDROME?
Reduction in size of a thyrotropin- and gonadotropin-secreting pituitary adenoma treated with octreotide acetate (somatostatin analog).
Pregnancy and delivery under bromocriptine therapy.
Reduction of infarct size--a rational aim?
Tumor suppression by MEG3 lncRNA in a human pituitary tumor derived cell line.
Painful clitoral tumescence during bromocriptine therapy.
Effect of reserpine on the inhibition of prolactin released from different pituitary constructs in vitro by dopamine, bromocriptine and apomorphine.
Reduction of glycine particle size by impinging jet crystallization.
Acromegaly first diagnosed in pregnancy: the role of bromocriptine therapy.
The influence of the channel size on the reduction of side effects in microchannel proton therapy.
Resumption of pituitary and ovarian activity post-partum: endocrine and ultrasonic observations in bromocriptine-treated women.
Ultrastructure of a mammosomatotrophic and a nonfunctional transplantable pituitary tumor induced in rats by 2,4,6-trimethylaniline.
Reduction in size of a pituitary tumor by bromocriptine therapy.
The New England Journal of Medicine Downloaded from nejm.org at UNIVERSITY OF OTAGO on November 15, 2015. For personal use only. No other uses without...
2MB Sizes
0 Downloads
0 Views
Download PDF
Recommend Documents
Effects of bromocriptine on pituitary tumour size.
Bromocriptine in pituitary tumours.
Bromocriptine and pituitary disorders.
Bromocriptine therapy in acromegaly.
Effect of delay in retroperfusion therapy on infarct size reduction.
Bromocriptine and Triac therapy for hyperthyroidism due to pituitary resistance to thyroid hormone.
Pituitary tumours during pregnancy in mothers treated with bromocriptine.
Pituitary size in depression.
Regression of pituitary prolactinoma after treatment with bromocriptine.
Hyperlipoproteinemia induced by a transplantable pituitary tumor in the rat.
×
Sign In
Login with Facebook
Don't have an account?
Forgot Password?
×
Sign Up
By clicking register, I agree to your terms